Jasper Therapeutics
JSPR
JSPR
44 hedge funds and large institutions have $169M invested in Jasper Therapeutics in 2023 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 14 increasing their positions, 2 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
100% more funds holding
Funds holding: 22 → 44 (+22)
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
3.1% more ownership
Funds ownership: 5.46% → 8.56% (+3.1%)
Holders
44
Holding in Top 10
3
Calls
$182K
Puts
$71K
Top Buyers
| 1 | +$17.9M | |
| 2 | +$15.8M | |
| 3 | +$14M | |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$13.5M |
| 5 |
OCA
Octagon Capital Advisors
New York
|
+$11.6M |
Top Sellers
| 1 | -$152K | |
| 2 | -$103K | |
| 3 | -$37.2K | |
| 4 |
VF
Virtu Financial
New York
|
-$7K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$6K |